Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
CNH
CNH Industrial
CNH
|
+$67.6M |
| 2 |
COLE
COLE REAL ESTATE INVESTMENTS, INC COM
COLE
|
+$43.4M |
| 3 |
Merck
MRK
|
+$42M |
| 4 |
Qualcomm
QCOM
|
+$36.1M |
| 5 |
Crown Castle
CCI
|
+$32.5M |
Top Sells
| 1 |
Annaly Capital Management
NLY
|
+$55.5M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$54.5M |
| 3 |
AGNC Investment
AGNC
|
+$45M |
| 4 |
Realty Income
O
|
+$39.8M |
| 5 |
Freeport-McMoran
FCX
|
+$37.3M |
Sector Composition
| 1 | Technology | 13.28% |
| 2 | Healthcare | 12.93% |
| 3 | Energy | 11.94% |
| 4 | Industrials | 11.4% |
| 5 | Consumer Staples | 10.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
Synovus
SNV
$7.2B
| $2.92M | 0.01% |
116,000
+1,329
| +1% | +$33.5K |
|
|
ACC
852
DELISTED
American Campus Communities, Inc.
ACC
| $2.92M | 0.01% |
90,700
| – | – |
|
|
ARRS
853
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $2.92M | 0.01% |
119,700
+8,200
| +7% | +$200K |
|
|
UPL
854
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $2.91M | 0.01% |
134,297
+7,097
| +6% | +$154K |
|
|
ATML
855
DELISTED
ATMEL CORP
ATML
| $2.89M | 0.01% |
369,100
| – | – |
|
856
Hancock Whitney
HWC
$5.33B
| $2.89M | 0.01% |
78,700
-1,000
| -1% | -$36.7K |
|
857
World Kinect Corp
WKC
$1.47B
| $2.87M | 0.01% |
66,600
+500
| +0.8% | +$21.6K |
|
858
MRC Global
MRC
$1.26B
| $2.87M | 0.01% |
+89,049
| New | +$2.87M |
|
|
CAB
859
DELISTED
Cabela's Inc
CAB
| $2.87M | 0.01% |
43,100
+300
| +0.7% | +$20K |
|
|
FWLT
860
DELISTED
FOSTER WHEELER AG (SWITZERLAND)
FWLT
| $2.87M | 0.01% |
87,000
| – | – |
|
|
NATI
861
DELISTED
National Instruments Corp
NATI
| $2.86M | 0.01% |
89,400
+1,100
| +1% | +$35.2K |
|
862
Cabot Corp
CBT
$4.31B
| $2.86M | 0.01% |
55,600
+400
| +0.7% | +$20.6K |
|
|
NFX
863
DELISTED
Newfield Exploration
NFX
| $2.86M | 0.01% |
115,992
+592
| +0.5% | +$14.6K |
|
864
Teradyne
TER
$18.3B
| $2.85M | 0.01% |
161,800
-6,200
| -4% | -$109K |
|
|
VPHM
865
DELISTED
VIROPHARMA INC
VPHM
| $2.84M | 0.01% |
57,000
+500
| +0.9% | +$24.9K |
|
866
Bio-Techne
TECH
$8.42B
| $2.84M | 0.01% |
120,000
+800
| +0.7% | +$18.9K |
|
867
Commault Systems
CVLT
$8.23B
| $2.84M | 0.01% |
37,900
+400
| +1% | +$30K |
|
|
CPHD
868
DELISTED
Cepheid Inc
CPHD
| $2.83M | 0.01% |
60,600
+3,400
| +6% | +$159K |
|
869
Avient
AVNT
$3.47B
| $2.82M | 0.01% |
79,800
-900
| -1% | -$31.8K |
|
|
QCOR
870
DELISTED
QUESTCOR PHARMA INC
QCOR
| $2.82M | 0.01% |
51,800
+600
| +1% | +$32.7K |
|
|
WCG
871
DELISTED
Wellcare Health Plans, Inc.
WCG
| $2.82M | 0.01% |
40,000
+300
| +0.8% | +$21.1K |
|
|
CYT
872
DELISTED
CYTEC INDS INC
CYT
| $2.81M | 0.01% |
60,400
-10,400
| -15% | -$484K |
|
|
WRI
873
DELISTED
Weingarten Realty Investors
WRI
| $2.8M | 0.01% |
102,000
+800
| +0.8% | +$21.9K |
|
|
NSR
874
DELISTED
Neustar Inc
NSR
| $2.8M | 0.01% |
56,100
-500
| -0.9% | -$24.9K |
|
|
SGI
875
Somnigroup International Inc.
SGI
$18.1B
| $2.77M | 0.01% |
205,600
| – | – |
|